1-year Clinical Outcomes in Recombinant Tissue Plasminogen Activator (Rt-PA) Treated Chinese Acute Ischaemic Stroke (AIS) Patients
Clinical trial NCT05395338 · COMPLETED
Trial details
- NCT number
- NCT05395338
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-04-12
- Primary completion
- 2022-11-30
- Enrollment
- 12551
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.